Stock Information
Fulcrum Therapeutics Inc (FULC)
Ticker Symbol: FULC
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $435.11 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.8985
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -22.54%
Latest News
-
Fulcrum Therapeutics (NASDAQ:FULC) Beats Q1 Estimates as Pociredir Data Fuels Optimism
Mon, Apr 27, 2026 12:20 PM
-
Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call Transcript
Mon, Apr 27, 2026 11:21 AM
-
Fulcrum Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Mon, Apr 27, 2026 10:35 AM
-
Fulcrum Therapeutics : Corporate Presentation - April 2026
Mon, Apr 27, 2026 9:20 AM
-
Transcript : Fulcrum Therapeutics, Inc., Q1 2026 Earnings Call, Apr 27, 2026
Mon, Apr 27, 2026 9:05 AM
-
Fulcrum Therapeutics Q1 2026 Earnings Call: Complete Transcript
Mon, Apr 27, 2026 8:58 AM
-
Fulcrum Therapeutics, Inc. Announces Retirement of Alan Musso as Chief Financial Officer
Mon, Apr 27, 2026 8:50 AM
-
Fulcrum Therapeutics, Inc. Appoints Josh Lehrer to Board of Directors
Mon, Apr 27, 2026 8:50 AM
-
Earnings Scheduled For April 27, 2026
Mon, Apr 27, 2026 7:11 AM
-
Fulcrum Therapeutics Q1 EPS $(0.25) Beats $(0.30) Estimate, Ended The First Quarter Of 2026 With $333.3M In Cash, Cash Equivalents, And Marketable Securities; Cash Runway Into 2029
Mon, Apr 27, 2026 7:02 AM
Key Financials
Financial data not available
